Sun Yat-sen University Cancer Center中山大学肿瘤防治中心
Li Shengping
Cancer Care

Li Shengping

李升平

Chief Physician & Professor, Hepatobiliary Surgery

Sun Yat-sen University Cancer Center中山大学肿瘤防治中心· Guangzhou

Areas of Expertise

Liver cancerLocally advanced pancreatic cancer (NanoKnife/IRE)Biliary tract cancerLiver metastasesUnresectable pancreatic tumors
Request Consultation with Shengping

Professional Biography

Dr. Li Shengping is Chief Physician & Professor, Hepatobiliary Surgery at Sun Yat-sen University Cancer Center, Guangzhou. Medical degree and hepatobiliary surgery training.

Education & Training

  • Medical degree and hepatobiliary surgery training
  • Training in NanoKnife/IRE technology

Leadership & Board Memberships

  • Chief of Hepatobiliary Surgery, SYSUCC
  • National NanoKnife clinical research leader

Pioneering Contributions

1

First in China to introduce NanoKnife (Irreversible Electroporation, IRE) for locally advanced pancreatic cancer (2015)

2

Demonstrated 2–3x survival extension: median OS 24.9 months vs. ~11 months for chemotherapy alone

3

Applied NanoKnife to 1,000+ patients at SYSUCC

International Patient Services

Full support for your journey to China

Medipath provides comprehensive support for international patients. Services include full English-speaking medical consultations, dedicated medical translation staff, and specialized assistance with medical visa applications to ensure a seamless healthcare journey.

English Consultations

Full English-speaking medical appointments

Medical Translation

Dedicated translation for all documentation

Visa Assistance

Medical visa application support